IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $710,771 | +79.3% | 73,808 | +98.1% | 0.09% | +72.0% |
| Q2 2023 | $396,489 | +11.5% | 37,264 | +10.2% | 0.05% | +25.0% |
| Q1 2023 | $355,692 | -61.7% | 33,811 | -54.9% | 0.04% | -62.3% |
| Q4 2022 | $929,362 | -49.1% | 75,009 | -57.4% | 0.11% | -46.7% |
| Q3 2022 | $1,826,000 | +194.5% | 176,248 | +227.9% | 0.20% | +226.2% |
| Q2 2022 | $620,000 | +210.0% | 53,744 | +237.8% | 0.06% | +190.5% |
| Q1 2022 | $200,000 | -87.7% | 15,910 | -88.8% | 0.02% | -82.6% |
| Q4 2020 | $1,621,000 | +48.9% | 142,346 | +17.6% | 0.12% | +72.9% |
| Q3 2020 | $1,089,000 | – | 121,070 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |